20
Participants
Start Date
March 17, 2017
Primary Completion Date
October 24, 2018
Study Completion Date
December 3, 2018
PlasmaBlade 3.0S
PlasmaBlade (Medtronic) is approved by United States Food and Drug Administration (FDA) as a low thermal dissection device that has shown to be associated with effective cutting, and significantly lower temperature than traditional electrosurgical dissection devices.
Bayview Medical Center, Baltimore
Johns Hopkins Hospital Outpatient Center, Baltimore
Collaborators (1)
Medtronic
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER